nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Doxorubicin—muscle cancer	0.361	1	CiPCiCtD
Etoposide—PTGS2—muscle cancer	0.0757	1	CbGaD
Etoposide—hematologic cancer—muscle cancer	0.0597	0.187	CtDrD
Etoposide—uterine cancer—muscle cancer	0.0489	0.153	CtDrD
Etoposide—urinary bladder cancer—muscle cancer	0.0458	0.143	CtDrD
Etoposide—ABCC6—Dactinomycin—muscle cancer	0.0376	0.189	CbGbCtD
Etoposide—testicular cancer—muscle cancer	0.0364	0.114	CtDrD
Etoposide—germ cell cancer—muscle cancer	0.0348	0.109	CtDrD
Etoposide—peripheral nervous system neoplasm—muscle cancer	0.0321	0.1	CtDrD
Etoposide—lung cancer—muscle cancer	0.0313	0.0979	CtDrD
Etoposide—sarcoma—muscle cancer	0.0309	0.0967	CtDrD
Etoposide—ABCC10—Vincristine—muscle cancer	0.0177	0.0887	CbGbCtD
Etoposide—ABCC6—Doxorubicin—muscle cancer	0.0145	0.0726	CbGbCtD
Etoposide—ABCC3—Vincristine—muscle cancer	0.0111	0.0558	CbGbCtD
Etoposide—ABCC1—Dactinomycin—muscle cancer	0.0111	0.0556	CbGbCtD
Etoposide—ABCC10—Doxorubicin—muscle cancer	0.011	0.0555	CbGbCtD
Etoposide—ABCC10—Methotrexate—muscle cancer	0.0107	0.0537	CbGbCtD
Etoposide—TOP2A—Doxorubicin—muscle cancer	0.00769	0.0386	CbGbCtD
Etoposide—ABCG2—Dactinomycin—muscle cancer	0.00741	0.0372	CbGbCtD
Etoposide—ABCC3—Doxorubicin—muscle cancer	0.00695	0.0349	CbGbCtD
Etoposide—ABCC1—Vincristine—muscle cancer	0.00682	0.0343	CbGbCtD
Etoposide—ABCC3—Methotrexate—muscle cancer	0.00673	0.0338	CbGbCtD
Etoposide—CYP2E1—Dacarbazine—muscle cancer	0.0061	0.0306	CbGbCtD
Etoposide—ABCC2—Vincristine—muscle cancer	0.00505	0.0254	CbGbCtD
Etoposide—ABCG2—Vincristine—muscle cancer	0.00457	0.0229	CbGbCtD
Etoposide—ABCC1—Doxorubicin—muscle cancer	0.00426	0.0214	CbGbCtD
Etoposide—ABCC1—Methotrexate—muscle cancer	0.00413	0.0207	CbGbCtD
Etoposide—CYP1A2—Dacarbazine—muscle cancer	0.00353	0.0177	CbGbCtD
Etoposide—ABCC2—Doxorubicin—muscle cancer	0.00316	0.0159	CbGbCtD
Etoposide—ABCC2—Methotrexate—muscle cancer	0.00306	0.0154	CbGbCtD
Etoposide—ABCG2—Doxorubicin—muscle cancer	0.00285	0.0143	CbGbCtD
Etoposide—ABCG2—Methotrexate—muscle cancer	0.00276	0.0139	CbGbCtD
Etoposide—ABCB1—Dactinomycin—muscle cancer	0.00267	0.0134	CbGbCtD
Etoposide—CYP3A5—Vincristine—muscle cancer	0.00253	0.0127	CbGbCtD
Etoposide—ABCB1—Vincristine—muscle cancer	0.00165	0.00827	CbGbCtD
Etoposide—ABCB1—Doxorubicin—muscle cancer	0.00103	0.00517	CbGbCtD
Etoposide—ABCB1—Methotrexate—muscle cancer	0.000997	0.00501	CbGbCtD
Etoposide—CYP3A4—Vincristine—muscle cancer	0.000986	0.00495	CbGbCtD
Etoposide—CYP3A4—Doxorubicin—muscle cancer	0.000617	0.0031	CbGbCtD
Etoposide—GSTT1—renal system—muscle cancer	0.000377	0.036	CbGeAlD
Etoposide—PTGS2—hindlimb—muscle cancer	0.000377	0.0359	CbGeAlD
Etoposide—TOP2B—embryo—muscle cancer	0.000367	0.035	CbGeAlD
Etoposide—PTGS2—appendage—muscle cancer	0.000323	0.0308	CbGeAlD
Etoposide—ABCC6—renal system—muscle cancer	0.000306	0.0292	CbGeAlD
Etoposide—TOP2B—smooth muscle tissue—muscle cancer	0.000289	0.0276	CbGeAlD
Etoposide—TOP2B—renal system—muscle cancer	0.000278	0.0265	CbGeAlD
Etoposide—GSTT1—head—muscle cancer	0.000253	0.0241	CbGeAlD
Etoposide—TOP2B—cardiac atrium—muscle cancer	0.000249	0.0238	CbGeAlD
Etoposide—TOP2A—Vindesine—Vincristine—muscle cancer	0.000247	0.336	CbGdCrCtD
Etoposide—GSTP1—embryo—muscle cancer	0.00023	0.0219	CbGeAlD
Etoposide—UGT1A1—renal system—muscle cancer	0.000221	0.0211	CbGeAlD
Etoposide—TOP2B—tendon—muscle cancer	0.000217	0.0207	CbGeAlD
Etoposide—TOP2B—bone marrow—muscle cancer	0.00021	0.0201	CbGeAlD
Etoposide—ABCC6—head—muscle cancer	0.000205	0.0196	CbGeAlD
Etoposide—TOP2B—vagina—muscle cancer	0.000201	0.0192	CbGeAlD
Etoposide—TOP2B—head—muscle cancer	0.000186	0.0177	CbGeAlD
Etoposide—GSTP1—smooth muscle tissue—muscle cancer	0.000181	0.0173	CbGeAlD
Etoposide—TOP2B—testis—muscle cancer	0.00018	0.0171	CbGeAlD
Etoposide—ABCC3—renal system—muscle cancer	0.000175	0.0167	CbGeAlD
Etoposide—GSTP1—renal system—muscle cancer	0.000174	0.0166	CbGeAlD
Etoposide—ABCC10—renal system—muscle cancer	0.000174	0.0166	CbGeAlD
Etoposide—TOP2A—tendon—muscle cancer	0.00016	0.0152	CbGeAlD
Etoposide—TOP2A—Vinorelbine—Vincristine—muscle cancer	0.000156	0.212	CbGdCrCtD
Etoposide—GSTP1—cardiac atrium—muscle cancer	0.000156	0.0149	CbGeAlD
Etoposide—ABCC10—cardiac atrium—muscle cancer	0.000156	0.0149	CbGeAlD
Etoposide—TOP2A—bone marrow—muscle cancer	0.000155	0.0147	CbGeAlD
Etoposide—TOP2A—vagina—muscle cancer	0.000148	0.0141	CbGeAlD
Etoposide—ABCC2—renal system—muscle cancer	0.00014	0.0133	CbGeAlD
Etoposide—GSTP1—tendon—muscle cancer	0.000136	0.013	CbGeAlD
Etoposide—ABCC10—tendon—muscle cancer	0.000136	0.013	CbGeAlD
Etoposide—TOP2A—testis—muscle cancer	0.000132	0.0126	CbGeAlD
Etoposide—GSTP1—bone marrow—muscle cancer	0.000132	0.0126	CbGeAlD
Etoposide—ABCC10—bone marrow—muscle cancer	0.000132	0.0126	CbGeAlD
Etoposide—GSTP1—vagina—muscle cancer	0.000126	0.012	CbGeAlD
Etoposide—ABCC10—vagina—muscle cancer	0.000126	0.012	CbGeAlD
Etoposide—ABCC3—head—muscle cancer	0.000117	0.0112	CbGeAlD
Etoposide—GSTP1—head—muscle cancer	0.000117	0.0111	CbGeAlD
Etoposide—ABCC3—testis—muscle cancer	0.000113	0.0108	CbGeAlD
Etoposide—GSTP1—testis—muscle cancer	0.000113	0.0107	CbGeAlD
Etoposide—ABCC10—testis—muscle cancer	0.000112	0.0107	CbGeAlD
Etoposide—ABCC1—cardiac atrium—muscle cancer	0.00011	0.0105	CbGeAlD
Etoposide—Pancytopenia—Dactinomycin—muscle cancer	0.000109	0.00333	CcSEcCtD
Etoposide—ABCC2—tendon—muscle cancer	0.000109	0.0104	CbGeAlD
Etoposide—Neutropenia—Dactinomycin—muscle cancer	0.000108	0.00328	CcSEcCtD
Etoposide—TOP2A—Vinblastine—Vincristine—muscle cancer	0.000107	0.146	CbGdCrCtD
Etoposide—PTGS2—embryo—muscle cancer	0.000107	0.0102	CbGeAlD
Etoposide—Nail disorder—Doxorubicin—muscle cancer	0.000106	0.00324	CcSEcCtD
Etoposide—CYP2C8—renal system—muscle cancer	0.000105	0.01	CbGeAlD
Etoposide—Pneumonia—Dactinomycin—muscle cancer	0.000103	0.00315	CcSEcCtD
Etoposide—Hepatotoxicity—Methotrexate—muscle cancer	0.000103	0.00314	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.000102	0.0031	CcSEcCtD
Etoposide—Necrosis—Methotrexate—muscle cancer	0.000101	0.00309	CcSEcCtD
Etoposide—Stomatitis—Dactinomycin—muscle cancer	0.0001	0.00305	CcSEcCtD
Etoposide—CYP1A2—renal system—muscle cancer	9.81e-05	0.00936	CbGeAlD
Etoposide—Pancytopenia—Vincristine—muscle cancer	9.78e-05	0.00298	CcSEcCtD
Etoposide—Neutropenia—Vincristine—muscle cancer	9.63e-05	0.00293	CcSEcCtD
Etoposide—ABCC1—tendon—muscle cancer	9.61e-05	0.00917	CbGeAlD
Etoposide—Agranulocytosis—Dactinomycin—muscle cancer	9.59e-05	0.00292	CcSEcCtD
Etoposide—CYP3A5—renal system—muscle cancer	9.46e-05	0.00902	CbGeAlD
Etoposide—Apnoea—Methotrexate—muscle cancer	9.4e-05	0.00286	CcSEcCtD
Etoposide—Pneumonia—Vincristine—muscle cancer	9.24e-05	0.00281	CcSEcCtD
Etoposide—Extravasation—Methotrexate—muscle cancer	9.13e-05	0.00278	CcSEcCtD
Etoposide—Acute coronary syndrome—Vincristine—muscle cancer	9.05e-05	0.00276	CcSEcCtD
Etoposide—ABCC2—testis—muscle cancer	9.03e-05	0.00862	CbGeAlD
Etoposide—Myocardial infarction—Vincristine—muscle cancer	9e-05	0.00274	CcSEcCtD
Etoposide—Neuropathy peripheral—Vincristine—muscle cancer	9e-05	0.00274	CcSEcCtD
Etoposide—Stomatitis—Vincristine—muscle cancer	8.95e-05	0.00273	CcSEcCtD
Etoposide—ABCC1—vagina—muscle cancer	8.92e-05	0.00851	CbGeAlD
Etoposide—PTGS1—smooth muscle tissue—muscle cancer	8.83e-05	0.00842	CbGeAlD
Etoposide—CYP2E1—renal system—muscle cancer	8.82e-05	0.00842	CbGeAlD
Etoposide—Skin discolouration—Methotrexate—muscle cancer	8.82e-05	0.00269	CcSEcCtD
Etoposide—Necrosis—Doxorubicin—muscle cancer	8.79e-05	0.00268	CcSEcCtD
Etoposide—Erythema multiforme—Dactinomycin—muscle cancer	8.72e-05	0.00266	CcSEcCtD
Etoposide—Hyperuricaemia—Methotrexate—muscle cancer	8.59e-05	0.00261	CcSEcCtD
Etoposide—Flushing—Dactinomycin—muscle cancer	8.56e-05	0.00261	CcSEcCtD
Etoposide—PTGS1—renal system—muscle cancer	8.5e-05	0.00811	CbGeAlD
Etoposide—Rigors—Doxorubicin—muscle cancer	8.45e-05	0.00257	CcSEcCtD
Etoposide—PTGS2—smooth muscle tissue—muscle cancer	8.44e-05	0.00805	CbGeAlD
Etoposide—Ulcer—Methotrexate—muscle cancer	8.42e-05	0.00256	CcSEcCtD
Etoposide—Chills—Dactinomycin—muscle cancer	8.28e-05	0.00252	CcSEcCtD
Etoposide—Inflammation—Methotrexate—muscle cancer	8.21e-05	0.0025	CcSEcCtD
Etoposide—Hypoaesthesia—Vincristine—muscle cancer	8.2e-05	0.0025	CcSEcCtD
Etoposide—Alopecia—Dactinomycin—muscle cancer	8.15e-05	0.00248	CcSEcCtD
Etoposide—Urinary tract disorder—Vincristine—muscle cancer	8.14e-05	0.00248	CcSEcCtD
Etoposide—PTGS2—renal system—muscle cancer	8.12e-05	0.00775	CbGeAlD
Etoposide—Blood uric acid increased—Methotrexate—muscle cancer	8.11e-05	0.00247	CcSEcCtD
Etoposide—Urethral disorder—Vincristine—muscle cancer	8.08e-05	0.00246	CcSEcCtD
Etoposide—ABCC1—testis—muscle cancer	7.96e-05	0.00759	CbGeAlD
Etoposide—Extravasation—Doxorubicin—muscle cancer	7.9e-05	0.00241	CcSEcCtD
Etoposide—Cardiovascular disorder—Doxorubicin—muscle cancer	7.85e-05	0.00239	CcSEcCtD
Etoposide—ABCG2—bone marrow—muscle cancer	7.7e-05	0.00735	CbGeAlD
Etoposide—Cardiac disorder—Vincristine—muscle cancer	7.65e-05	0.00233	CcSEcCtD
Etoposide—Skin discolouration—Doxorubicin—muscle cancer	7.64e-05	0.00233	CcSEcCtD
Etoposide—PTGS1—cardiac atrium—muscle cancer	7.61e-05	0.00726	CbGeAlD
Etoposide—Skin exfoliation—Methotrexate—muscle cancer	7.6e-05	0.00232	CcSEcCtD
Etoposide—CYP2C8—vagina—muscle cancer	7.59e-05	0.00724	CbGeAlD
Etoposide—Cellulitis—Doxorubicin—muscle cancer	7.58e-05	0.00231	CcSEcCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—muscle cancer	7.53e-05	0.102	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—muscle cancer	7.53e-05	0.102	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—muscle cancer	7.53e-05	0.102	CbGdCrCtD
Etoposide—Angiopathy—Vincristine—muscle cancer	7.48e-05	0.00228	CcSEcCtD
Etoposide—Ill-defined disorder—Dactinomycin—muscle cancer	7.45e-05	0.00227	CcSEcCtD
Etoposide—Hyperuricaemia—Doxorubicin—muscle cancer	7.43e-05	0.00226	CcSEcCtD
Etoposide—Mediastinal disorder—Vincristine—muscle cancer	7.43e-05	0.00226	CcSEcCtD
Etoposide—Anaemia—Dactinomycin—muscle cancer	7.42e-05	0.00226	CcSEcCtD
Etoposide—ABCG2—vagina—muscle cancer	7.38e-05	0.00704	CbGeAlD
Etoposide—Ulcer—Doxorubicin—muscle cancer	7.29e-05	0.00222	CcSEcCtD
Etoposide—Alopecia—Vincristine—muscle cancer	7.28e-05	0.00222	CcSEcCtD
Etoposide—Malaise—Dactinomycin—muscle cancer	7.24e-05	0.00221	CcSEcCtD
Etoposide—Mouth ulceration—Methotrexate—muscle cancer	7.2e-05	0.00219	CcSEcCtD
Etoposide—Leukopenia—Dactinomycin—muscle cancer	7.19e-05	0.00219	CcSEcCtD
Etoposide—Inflammation—Doxorubicin—muscle cancer	7.11e-05	0.00217	CcSEcCtD
Etoposide—CYP3A4—renal system—muscle cancer	7.1e-05	0.00677	CbGeAlD
Etoposide—Blood uric acid increased—Doxorubicin—muscle cancer	7.02e-05	0.00214	CcSEcCtD
Etoposide—Back pain—Vincristine—muscle cancer	6.94e-05	0.00211	CcSEcCtD
Etoposide—Sepsis—Methotrexate—muscle cancer	6.91e-05	0.0021	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Doxorubicin—muscle cancer	6.9e-05	0.0021	CcSEcCtD
Etoposide—CYP2E1—tendon—muscle cancer	6.89e-05	0.00657	CbGeAlD
Etoposide—CYP3A5—vagina—muscle cancer	6.85e-05	0.00654	CbGeAlD
Etoposide—CYP2C8—testis—muscle cancer	6.77e-05	0.00646	CbGeAlD
Etoposide—Discomfort—Dactinomycin—muscle cancer	6.76e-05	0.00206	CcSEcCtD
Etoposide—ABCB1—embryo—muscle cancer	6.64e-05	0.00633	CbGeAlD
Etoposide—PTGS1—tendon—muscle cancer	6.63e-05	0.00633	CbGeAlD
Etoposide—Anaemia—Vincristine—muscle cancer	6.63e-05	0.00202	CcSEcCtD
Etoposide—ABCG2—testis—muscle cancer	6.59e-05	0.00628	CbGeAlD
Etoposide—Candida infection—Doxorubicin—muscle cancer	6.58e-05	0.002	CcSEcCtD
Etoposide—Skin exfoliation—Doxorubicin—muscle cancer	6.58e-05	0.002	CcSEcCtD
Etoposide—Infection—Dactinomycin—muscle cancer	6.51e-05	0.00198	CcSEcCtD
Etoposide—Neuropathy—Doxorubicin—muscle cancer	6.48e-05	0.00197	CcSEcCtD
Etoposide—Vertigo—Vincristine—muscle cancer	6.45e-05	0.00196	CcSEcCtD
Etoposide—Leukopenia—Vincristine—muscle cancer	6.42e-05	0.00196	CcSEcCtD
Etoposide—Thrombocytopenia—Dactinomycin—muscle cancer	6.42e-05	0.00195	CcSEcCtD
Etoposide—PTGS2—tendon—muscle cancer	6.34e-05	0.00605	CbGeAlD
Etoposide—Oesophagitis—Doxorubicin—muscle cancer	6.3e-05	0.00192	CcSEcCtD
Etoposide—Rash maculo-papular—Doxorubicin—muscle cancer	6.27e-05	0.00191	CcSEcCtD
Etoposide—Anorexia—Dactinomycin—muscle cancer	6.25e-05	0.0019	CcSEcCtD
Etoposide—Mouth ulceration—Doxorubicin—muscle cancer	6.24e-05	0.0019	CcSEcCtD
Etoposide—Convulsion—Vincristine—muscle cancer	6.22e-05	0.00189	CcSEcCtD
Etoposide—Hypertension—Vincristine—muscle cancer	6.2e-05	0.00189	CcSEcCtD
Etoposide—PTGS1—vagina—muscle cancer	6.16e-05	0.00587	CbGeAlD
Etoposide—PTGS2—bone marrow—muscle cancer	6.14e-05	0.00586	CbGeAlD
Etoposide—Sepsis—Doxorubicin—muscle cancer	5.98e-05	0.00182	CcSEcCtD
Etoposide—Anaphylactoid reaction—Methotrexate—muscle cancer	5.97e-05	0.00182	CcSEcCtD
Etoposide—CYP2E1—head—muscle cancer	5.9e-05	0.00563	CbGeAlD
Etoposide—PTGS2—vagina—muscle cancer	5.88e-05	0.00561	CbGeAlD
Etoposide—Anaphylactic shock—Vincristine—muscle cancer	5.86e-05	0.00178	CcSEcCtD
Etoposide—Infection—Vincristine—muscle cancer	5.82e-05	0.00177	CcSEcCtD
Etoposide—Phlebitis—Doxorubicin—muscle cancer	5.81e-05	0.00177	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Doxorubicin—muscle cancer	5.76e-05	0.00175	CcSEcCtD
Etoposide—Thrombocytopenia—Vincristine—muscle cancer	5.73e-05	0.00175	CcSEcCtD
Etoposide—CYP2E1—testis—muscle cancer	5.7e-05	0.00544	CbGeAlD
Etoposide—Decreased appetite—Dactinomycin—muscle cancer	5.7e-05	0.00174	CcSEcCtD
Etoposide—PTGS1—head—muscle cancer	5.69e-05	0.00542	CbGeAlD
Etoposide—Hyperhidrosis—Vincristine—muscle cancer	5.66e-05	0.00172	CcSEcCtD
Etoposide—Fatigue—Dactinomycin—muscle cancer	5.65e-05	0.00172	CcSEcCtD
Etoposide—Pain—Dactinomycin—muscle cancer	5.61e-05	0.00171	CcSEcCtD
Etoposide—Anorexia—Vincristine—muscle cancer	5.58e-05	0.0017	CcSEcCtD
Etoposide—Cardiac failure congestive—Doxorubicin—muscle cancer	5.52e-05	0.00168	CcSEcCtD
Etoposide—PTGS1—testis—muscle cancer	5.49e-05	0.00524	CbGeAlD
Etoposide—Hypotension—Vincristine—muscle cancer	5.47e-05	0.00167	CcSEcCtD
Etoposide—PTGS2—head—muscle cancer	5.43e-05	0.00519	CbGeAlD
Etoposide—Feeling abnormal—Dactinomycin—muscle cancer	5.4e-05	0.00164	CcSEcCtD
Etoposide—Gastrointestinal pain—Dactinomycin—muscle cancer	5.36e-05	0.00163	CcSEcCtD
Etoposide—Paraesthesia—Vincristine—muscle cancer	5.26e-05	0.0016	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Methotrexate—muscle cancer	5.21e-05	0.00159	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—muscle cancer	5.18e-05	0.00158	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—muscle cancer	5.18e-05	0.00158	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—muscle cancer	5.17e-05	0.00158	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—muscle cancer	5.13e-05	0.00156	CcSEcCtD
Etoposide—Decreased appetite—Vincristine—muscle cancer	5.09e-05	0.00155	CcSEcCtD
Etoposide—Gastrointestinal disorder—Vincristine—muscle cancer	5.06e-05	0.00154	CcSEcCtD
Etoposide—Fatigue—Vincristine—muscle cancer	5.05e-05	0.00154	CcSEcCtD
Etoposide—ABCB1—renal system—muscle cancer	5.02e-05	0.00479	CbGeAlD
Etoposide—Pain—Vincristine—muscle cancer	5.01e-05	0.00152	CcSEcCtD
Etoposide—Constipation—Vincristine—muscle cancer	5.01e-05	0.00152	CcSEcCtD
Etoposide—Hypersensitivity—Dactinomycin—muscle cancer	4.83e-05	0.00147	CcSEcCtD
Etoposide—Gastrointestinal pain—Vincristine—muscle cancer	4.79e-05	0.00146	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—muscle cancer	4.76e-05	0.00145	CcSEcCtD
Etoposide—Pancytopenia—Methotrexate—muscle cancer	4.75e-05	0.00145	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—muscle cancer	4.7e-05	0.00143	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—muscle cancer	4.67e-05	0.00142	CcSEcCtD
Etoposide—Abdominal pain—Vincristine—muscle cancer	4.63e-05	0.00141	CcSEcCtD
Etoposide—Body temperature increased—Vincristine—muscle cancer	4.63e-05	0.00141	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	4.51e-05	0.00137	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—muscle cancer	4.48e-05	0.00137	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—muscle cancer	4.48e-05	0.00136	CcSEcCtD
Etoposide—Infestation—Methotrexate—muscle cancer	4.46e-05	0.00136	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—muscle cancer	4.46e-05	0.00136	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	4.42e-05	0.00135	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—muscle cancer	4.42e-05	0.00134	CcSEcCtD
Etoposide—Renal failure—Methotrexate—muscle cancer	4.38e-05	0.00133	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—muscle cancer	4.34e-05	0.00132	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—muscle cancer	4.33e-05	0.00132	CcSEcCtD
Etoposide—Hypersensitivity—Vincristine—muscle cancer	4.31e-05	0.00131	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—muscle cancer	4.21e-05	0.00128	CcSEcCtD
Etoposide—Asthenia—Vincristine—muscle cancer	4.2e-05	0.00128	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—muscle cancer	4.17e-05	0.00127	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—muscle cancer	4.16e-05	0.00127	CcSEcCtD
Etoposide—Rash—Dactinomycin—muscle cancer	4.13e-05	0.00126	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—muscle cancer	4.11e-05	0.00125	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—muscle cancer	4.05e-05	0.00123	CcSEcCtD
Etoposide—Diarrhoea—Vincristine—muscle cancer	4.01e-05	0.00122	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—muscle cancer	3.95e-05	0.0012	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—muscle cancer	3.92e-05	0.00119	CcSEcCtD
Etoposide—Nausea—Dactinomycin—muscle cancer	3.89e-05	0.00119	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—muscle cancer	3.88e-05	0.00118	CcSEcCtD
Etoposide—Dizziness—Vincristine—muscle cancer	3.87e-05	0.00118	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—muscle cancer	3.86e-05	0.00117	CcSEcCtD
Etoposide—Infestation—Doxorubicin—muscle cancer	3.86e-05	0.00117	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	3.83e-05	0.00116	CcSEcCtD
Etoposide—ABCB1—bone marrow—muscle cancer	3.8e-05	0.00362	CbGeAlD
Etoposide—Renal failure—Doxorubicin—muscle cancer	3.79e-05	0.00115	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—muscle cancer	3.78e-05	0.00115	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—muscle cancer	3.78e-05	0.00115	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—muscle cancer	3.76e-05	0.00115	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—muscle cancer	3.76e-05	0.00115	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—muscle cancer	3.74e-05	0.00114	CcSEcCtD
Etoposide—Vomiting—Vincristine—muscle cancer	3.72e-05	0.00113	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—muscle cancer	3.71e-05	0.00113	CcSEcCtD
Etoposide—Rash—Vincristine—muscle cancer	3.69e-05	0.00112	CcSEcCtD
Etoposide—Dermatitis—Vincristine—muscle cancer	3.69e-05	0.00112	CcSEcCtD
Etoposide—Headache—Vincristine—muscle cancer	3.67e-05	0.00112	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—muscle cancer	3.65e-05	0.00111	CcSEcCtD
Etoposide—ABCB1—vagina—muscle cancer	3.64e-05	0.00347	CbGeAlD
Etoposide—Angiopathy—Methotrexate—muscle cancer	3.63e-05	0.00111	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—muscle cancer	3.61e-05	0.0011	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—muscle cancer	3.6e-05	0.0011	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—muscle cancer	3.6e-05	0.0011	CcSEcCtD
Etoposide—Chills—Methotrexate—muscle cancer	3.59e-05	0.00109	CcSEcCtD
Etoposide—Alopecia—Methotrexate—muscle cancer	3.53e-05	0.00108	CcSEcCtD
Etoposide—Nausea—Vincristine—muscle cancer	3.48e-05	0.00106	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—muscle cancer	3.45e-05	0.00105	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—muscle cancer	3.42e-05	0.00104	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—muscle cancer	3.41e-05	0.00104	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—muscle cancer	3.4e-05	0.00103	CcSEcCtD
Etoposide—Back pain—Methotrexate—muscle cancer	3.37e-05	0.00103	CcSEcCtD
Etoposide—ABCB1—head—muscle cancer	3.36e-05	0.00321	CbGeAlD
Etoposide—Erythema multiforme—Doxorubicin—muscle cancer	3.27e-05	0.000997	CcSEcCtD
Etoposide—ABCB1—testis—muscle cancer	3.25e-05	0.0031	CbGeAlD
Etoposide—Eye disorder—Doxorubicin—muscle cancer	3.24e-05	0.000986	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—muscle cancer	3.23e-05	0.000984	CcSEcCtD
Etoposide—Anaemia—Methotrexate—muscle cancer	3.22e-05	0.00098	CcSEcCtD
Etoposide—Flushing—Doxorubicin—muscle cancer	3.21e-05	0.000979	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—muscle cancer	3.21e-05	0.000979	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—muscle cancer	3.14e-05	0.000957	CcSEcCtD
Etoposide—Malaise—Methotrexate—muscle cancer	3.14e-05	0.000956	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—muscle cancer	3.13e-05	0.000953	CcSEcCtD
Etoposide—Vertigo—Methotrexate—muscle cancer	3.13e-05	0.000953	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—muscle cancer	3.12e-05	0.00095	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—muscle cancer	3.12e-05	0.000949	CcSEcCtD
Etoposide—Chills—Doxorubicin—muscle cancer	3.11e-05	0.000946	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—muscle cancer	3.06e-05	0.000932	CcSEcCtD
Etoposide—Cough—Methotrexate—muscle cancer	3.04e-05	0.000925	CcSEcCtD
Etoposide—Convulsion—Methotrexate—muscle cancer	3.02e-05	0.000919	CcSEcCtD
Etoposide—Chest pain—Methotrexate—muscle cancer	2.96e-05	0.000903	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—muscle cancer	2.95e-05	0.000899	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	2.94e-05	0.000896	CcSEcCtD
Etoposide—Discomfort—Methotrexate—muscle cancer	2.93e-05	0.000892	CcSEcCtD
Etoposide—Back pain—Doxorubicin—muscle cancer	2.92e-05	0.000888	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—muscle cancer	2.9e-05	0.000883	CcSEcCtD
Etoposide—Confusional state—Methotrexate—muscle cancer	2.87e-05	0.000872	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—muscle cancer	2.84e-05	0.000865	CcSEcCtD
Etoposide—Infection—Methotrexate—muscle cancer	2.82e-05	0.00086	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—muscle cancer	2.8e-05	0.000852	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—muscle cancer	2.79e-05	0.000849	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—muscle cancer	2.78e-05	0.000847	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—muscle cancer	2.76e-05	0.00084	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—muscle cancer	2.75e-05	0.000836	CcSEcCtD
Etoposide—Malaise—Doxorubicin—muscle cancer	2.72e-05	0.000828	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—muscle cancer	2.71e-05	0.000825	CcSEcCtD
Etoposide—Anorexia—Methotrexate—muscle cancer	2.71e-05	0.000825	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—muscle cancer	2.7e-05	0.000822	CcSEcCtD
Etoposide—Hypotension—Methotrexate—muscle cancer	2.66e-05	0.000809	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—muscle cancer	2.65e-05	0.000807	CcSEcCtD
Etoposide—Cough—Doxorubicin—muscle cancer	2.63e-05	0.000801	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—muscle cancer	2.61e-05	0.000795	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—muscle cancer	2.6e-05	0.000793	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—muscle cancer	2.57e-05	0.000782	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—muscle cancer	2.55e-05	0.000777	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	2.55e-05	0.000776	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—muscle cancer	2.54e-05	0.000772	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—muscle cancer	2.53e-05	0.000771	CcSEcCtD
Etoposide—Somnolence—Methotrexate—muscle cancer	2.53e-05	0.000769	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—muscle cancer	2.48e-05	0.000755	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—muscle cancer	2.47e-05	0.000752	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—muscle cancer	2.46e-05	0.000749	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—muscle cancer	2.45e-05	0.000747	CcSEcCtD
Etoposide—Fatigue—Methotrexate—muscle cancer	2.45e-05	0.000746	CcSEcCtD
Etoposide—Infection—Doxorubicin—muscle cancer	2.44e-05	0.000744	CcSEcCtD
Etoposide—Pain—Methotrexate—muscle cancer	2.43e-05	0.00074	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—muscle cancer	2.41e-05	0.000734	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—muscle cancer	2.4e-05	0.000731	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—muscle cancer	2.39e-05	0.000728	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—muscle cancer	2.38e-05	0.000724	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—muscle cancer	2.35e-05	0.000714	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—muscle cancer	2.34e-05	0.000713	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—muscle cancer	2.32e-05	0.000708	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—muscle cancer	2.3e-05	0.0007	CcSEcCtD
Etoposide—Urticaria—Methotrexate—muscle cancer	2.26e-05	0.000687	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—muscle cancer	2.25e-05	0.000684	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—muscle cancer	2.25e-05	0.000684	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—muscle cancer	2.21e-05	0.000673	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—muscle cancer	2.19e-05	0.000668	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—muscle cancer	2.19e-05	0.000666	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—muscle cancer	2.14e-05	0.000651	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—muscle cancer	2.12e-05	0.000647	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—muscle cancer	2.12e-05	0.000646	CcSEcCtD
Etoposide—Constipation—Doxorubicin—muscle cancer	2.1e-05	0.000641	CcSEcCtD
Etoposide—Pain—Doxorubicin—muscle cancer	2.1e-05	0.000641	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—muscle cancer	2.09e-05	0.000638	CcSEcCtD
Etoposide—Asthenia—Methotrexate—muscle cancer	2.04e-05	0.000621	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—muscle cancer	2.03e-05	0.000617	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—muscle cancer	2.01e-05	0.000613	CcSEcCtD
Etoposide—Pruritus—Methotrexate—muscle cancer	2.01e-05	0.000612	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—muscle cancer	1.95e-05	0.000595	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—muscle cancer	1.95e-05	0.000592	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—muscle cancer	1.95e-05	0.000592	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—muscle cancer	1.94e-05	0.000592	CcSEcCtD
Etoposide—Dizziness—Methotrexate—muscle cancer	1.88e-05	0.000572	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—muscle cancer	1.81e-05	0.000552	CcSEcCtD
Etoposide—Vomiting—Methotrexate—muscle cancer	1.81e-05	0.00055	CcSEcCtD
Etoposide—Rash—Methotrexate—muscle cancer	1.79e-05	0.000546	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—muscle cancer	1.79e-05	0.000545	CcSEcCtD
Etoposide—Headache—Methotrexate—muscle cancer	1.78e-05	0.000542	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—muscle cancer	1.77e-05	0.000538	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—muscle cancer	1.74e-05	0.00053	CcSEcCtD
Etoposide—Nausea—Methotrexate—muscle cancer	1.69e-05	0.000514	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—muscle cancer	1.68e-05	0.000513	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—muscle cancer	1.63e-05	0.000495	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—muscle cancer	1.56e-05	0.000476	CcSEcCtD
Etoposide—Rash—Doxorubicin—muscle cancer	1.55e-05	0.000472	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—muscle cancer	1.55e-05	0.000472	CcSEcCtD
Etoposide—Headache—Doxorubicin—muscle cancer	1.54e-05	0.000469	CcSEcCtD
Etoposide—Nausea—Doxorubicin—muscle cancer	1.46e-05	0.000445	CcSEcCtD
